Search





Search





Markets
/
Stocks
/
rvty
/

Revvity Inc

RVTY

Add to Watchlist

112.520USD

-1.020-0.90%

Close 07-31 16:00（ET）Quotes delayed by 15 min

12.56BMarket Cap

54.04P/E TTM

Revvity Inc

112.520

-1.020-0.90%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.90%

5 Days

+1.86%

1 Month

+1.13%

6 Months

+3.42%

Year to Date

+16.30%

1 Year

+28.01%

Key Figures

113.990Open

114.150High

1.21MVolume

54.04P/E TTM

19.35P/E Dynamic

0.280Dividend TTM

1.08%Turnover Ratio

113.540Prev. Close

110.950Low

71.55MTurnover

46.45P/E Static

1.75P/B

0.25%Div Yield TTM

1.96%ROA

118.30052wk High

0.70Volume Ratio

270.38MNet Profit

111.63MShares

2.0821EPS TTM

1.12Beta

3.23%ROE

81.36052wk Low

2.82%Amplitude

54.51%Gross Margin

12.56BMarket Cap

-0.09Reward/Risk

2.10%Risk Rate

TradingKey Stock Score of Revvity Inc

Currency: USD Updated: 2026-07-31

Key Insights

Revvity Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 114.29.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Revvity Inc's Score

Industry at a Glance

Industry Ranking

31 / 199

Overall Ranking

86 / 4281

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative-

Revvity Inc Highlights

StrengthsRisks

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.14%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.14%.

Overvalued

The company’s latest PE is 54.04, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 116.42M shares, decreasing 9.50% quarter-over-quarter.

Held by EDGEPOINT CANADIAN PORTFOLIO

Star Investor EDGEPOINT CANADIAN PORTFOLIO holds 7.96M shares of this stock.

Analyst Rating

Based on 19 analysts

Buy

Current Rating

114.289

Target Price

+0.81%

Upside Space

Revvity Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 19 analysts

Buy

Current Rating

114.289

Target Price

+0.81%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Revvity Inc

RVTY

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Thermo Fisher Scientific Inc

TMO

Veeva Systems Inc

VEEV

...

Indicators

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.356

Neutral

RSI(14)

55.976

Neutral

STOCH(KDJ)(9,3,3)

75.317

Neutral

ATR(14)

3.762

High Vlolatility

CCI(14)

83.049

Neutral

Williams %R

25.523

Buy

TRIX(12,20)

0.182

Sell

StochRSI(14)

75.282

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

111.802

Buy

MA10

111.015

Buy

MA20

111.263

Buy

MA50

106.024

Buy

MA100

98.097

Buy

MA200

98.921

Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Revvity Inc Info

Ticker SymbolRVTY

CompanyRevvity Inc

CEOSingh (Prahlad R)

Websitehttps://www.revvity.com/

Shareholders

Shareholders

Proportion

T. Rowe Price Investment Management, Inc.

20.12%

EdgePoint Investment Group Inc.

7.65%

T. Rowe Price Associates, Inc.

7.56%

Janus Henderson Investors

7.32%

Vanguard Capital Management, LLC

6.57%

Other

50.78%

Popular Instruments

FAQs

What is the current price of Revvity Inc (RVTY)?



The current price of Revvity Inc (RVTY) is 112.52.

What is the symbol of Revvity Inc?



The ticker symbol of Revvity Inc is RVTY.

What is the 52-week high of Revvity Inc?



The 52-week high of Revvity Inc is 118.30.

What is the 52-week low of Revvity Inc?



The 52-week low of Revvity Inc is 81.36.

What is the market capitalization of Revvity Inc?



The market capitalization of Revvity Inc is 12.56B.

Is Revvity Inc (RVTY) currently rated as Buy, Hold, or Sell?



According to analysts, Revvity Inc (RVTY) has an overall rating of Buy, with a price target of 114.29.

What is the Earnings Per Share (EPS TTM) of Revvity Inc (RVTY)?



The Earnings Per Share (EPS TTM) of Revvity Inc (RVTY) is 2.07.